Zidovudine update: 1990. (Q37943002)

25 August 2017

1 reference

title

Zidovudine update: 1990. (English)

1 reference

25 August 2017

1 reference

Morse GD

1

1 reference

25 August 2017

Lechner JL

series ordinal

2

1 reference

25 August 2017

Santora JA

series ordinal

3

1 reference

25 August 2017

Rozek SL

series ordinal

4

1 reference

25 August 2017

1 July 1990

1 reference

DICP : the annals of pharmacotherapy

25 August 2017

1 reference

25 August 2017

24

1 reference

25 August 2017

7-8

1 reference

25 August 2017

754-760

1 reference

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

25 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

In vivo activity against HIV and favorable toxicity profile of 2',3'-dideoxyinosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Pharmacokinetics of orally administered zidovudine among patients with hemophilia and asymptomatic human immunodeficiency virus (HIV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Strategies for antiviral therapy in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Treatment of children symptomatic with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Zidovudine experience at the Hospitals for Sick Children, Great Ormond Street, London

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Post-exposure prophylaxis against HIV infection in health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Prophylactic zidovudine after occupational exposure to the human immunodeficiency virus: an interim analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Suppression of mouse viraemia and retroviral disease by 3'-azido-3'-deoxythymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Human immunodeficiency virus-associated myopathy: analysis of 11 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Drug-resistant strains of AIDS virus found

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

The acquired immunodeficiency syndrome in persons with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Zidovudine-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Probenecid and zidovudine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Phase I study of low-dose zidovudine and acyclovir in asymptomatic human immunodeficiency virus seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

Bioequivalence assessment of zidovudine (Retrovir) syrup, solution, and capsule formulations in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809002400720

10.1177/106002809002400720

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference